Copyright
©2014 Baishideng Publishing Group Inc.
World J Clin Cases. Aug 16, 2014; 2(8): 351-356
Published online Aug 16, 2014. doi: 10.12998/wjcc.v2.i8.351
Published online Aug 16, 2014. doi: 10.12998/wjcc.v2.i8.351
Table 2 Dose ranges and complications
| Patient | Dose range (mg/d) | Complications |
| 1 | 0.10-21.5 (morphine) | Nausea/Emesis (transient-decreased dosage) |
| 2.10-3.27 (dilaudid) | Changed medication due to inadequate pain control/nausea | |
| 2 | 0.65-19.0 (morphine) | Replacement of pump × 2 (q5 yr) |
| Withdrawal symptoms (transient) | ||
| 3 | 0.20 (dilaudid) | Psychiatric disturbances leading to removal of pain pump after 11 yr |
| 4 | 0.75-2.0 (morphine) | Nausea/ Emesis (transient- decreased dosage) |
| 5 | 4.00-4.25 (morphine) | Lost to follow-up after 1 yr |
| 6 | 0.01–0.10 (dilaudid) |
- Citation: Lee DJ, Gurkoff GG, Goodarzi A, Muizelaar JP, Boggan JE, Shahlaie K. Intracerebroventricular opiate infusion for refractory head and facial pain. World J Clin Cases 2014; 2(8): 351-356
- URL: https://www.wjgnet.com/2307-8960/full/v2/i8/351.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v2.i8.351